And all this earlier research was not enough?
leg compressions (16 posts to September 2015)
Remote ischemic conditioning (11 posts to July 2018)
leg wraps (7 posts to May 2013)
Leg wraps raise hopes of saved lives after strokes May 2013
Leg compressions may enhance stroke recovery August 2012
The latest here:
Remote ischemic conditioning for acute ischemic stroke part 2: Study protocol for a randomized controlled trial
- 1Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan
- 2Department of Public Health, Tokyo Women's Medical University School of Medicine, Tokyo, Japan
- 3Department of Stroke Medicine, Kawasaki Medical School, Okayama, Japan
- 4Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan
- 5Department of Neurology, Osaka General Medical Center, Osaka, Japan
- 6Department of Neurology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan
- 7Department of Neurology, Toda Chuo General Hospital, Saitama, Japan
- 8Department of Neurology, Saitama Red Cross Hospital, Saitama, Japan
- 9Department of Neurology, Showa General Hospital, Tokyo, Japan
- 10Department of Neurology, Iwate Prefectural Central Hospital, Iwate, Japan
- 11Department of Stroke Neurology, National Hospital Organization, Osaka National Hospital, Osaka, Japan
- 12Department of Neurology, The Jikei University School of Medicine, Tokyo, Japan
- 13Department of Stroke and Cerebrovascular Medicine, Kyorin University, Tokyo, Japan
- 14Department of Neurology, Nippon Medical School, Tokyo, Japan
- 15Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
Background: Remote ischemic conditioning (RIC) refers to the application of repeated short periods of ischemia intended to protect remote areas against tissue damage during and after prolonged ischemia.
Aim: We aim to evaluate the efficacy of RIC, determined by the modified Rankin Scale (mRS) score at 90 days after stroke onset.
Design and methods: This study is an investigator-initiated, multicenter, prospective, randomized, open-label, parallel-group clinical trial. The sample size is 400, comprising 200 patients who will receive RIC and 200 controls. The patients will be divided into three groups according to their National Institutes of Health Stroke Scale score at enrollment: 5–9, mild; 10–14, moderate; 15–20, severe. The RIC protocol will be comprised of four cycles, each consisting of 5 min of blood pressure cuff inflation (at 200 mmHg or 50 mmHg above the systolic blood pressure) followed by 5 min of reperfusion, with the cuff placed on the thigh on the unaffected side. The control group will only undergo blood pressure measurements before and after the intervention period. This trial is registered with the UMIN Clinical Trial Registry (https://www.umin.ac.jp/: UMIN000046225).
Study outcome: The primary outcome will be a good functional outcome as determined by the mRS score at 90 days after stroke onset, with a target mRS score of 0–1 in the mild group, 0–2 in the moderate group, and 0–3 in the severe group.
Discussion: This trial may help determine whether RIC should be recommended as a routine clinical strategy for patients with ischemic stroke.
Introduction
In recent years, hyperacute reperfusion treatment has progressed remarkably due to the establishment of recombinant tissue-type plasminogen activator (rt-PA) and endovascular treatment (EVT) (1, 2). Although Japan is proceeding with a plan to accelerate the development of an efficient care system for stroke patients (forming new stroke centers and stroke care units), only 6–8% of patients can receive hyperacute reperfusion therapy (3). In Japan, edaravone has been used as an effective method to reduce ischemic insults. However, it is not widely used internationally; it has yet to demonstrate sufficient efficacy (4).
Remote ischemic conditioning (RIC) is a therapeutic strategy in which several cycles of brief focal ischemia, followed by reperfusion in the arms or legs, confer protection against the more severe detrimental effects of ischemia in target organs (5–8). Although the underlying mechanisms are not fully understood, current evidence indicates that RIC reduces inflammation, oxidative stress, and cerebral edema, mediated by humoral, immunoregulatory, and neurotrophic factors (9). Although the clinical application of RIC in patients with acute ischemic stroke has been attempted, its efficacy has not yet been validated (10–12). Moreover, no clinical trials have been conducted on acute ischemic strokes in Japan.
One reason for the inability to confirm the efficacy of RIC in previous studies may be the use of a unified definition of a good outcome as assessed by the modified Rankin Scale (mRS), regardless of the neurological severity of the enrolled patients upon admission. Another reason may be the lack of an established RIC protocol. Therefore, this study aims to evaluate the efficacy of an RIC protocol based on recent literature, determined by the mRS score at 90 days after stroke onset, with a good outcome defined according to the severity at enrollment.
No comments:
Post a Comment